Colon cancer hijacks the body's repair switch — and scientists just found how to jam it

For colon cancer patients, the terror isn't the tumor — it's what comes after surgery. Even when everything is removed, up to one in three patients sees the cancer return in the liver or lungs, and for years nobody could find the trigger. An MIT team led by Omer Yilmaz just found it. Colon cancer cells flip on a repair program called YAP1 — the same switch a damaged gut uses to heal after injury. High-fat diets crank it harder by making fatty molecules called ceramides, which release the brake that normally keeps YAP1 locked off. In mice, disabling the enzymes that make ceramides kept the repair program dark and stopped cancer from seeding in the liver. The team, with colleagues at Harvard, Dana-Farber, and Germany's Essen University Hospital and German Cancer Consortium, published the work in Science — and two ceramide-making enzymes are their next drug targets.